Literature DB >> 12923337

Paradoxical therapy in conversion reaction.

Ahmet Ataoglu1, Adnan Ozcetin, Celalettin Icmeli, Omer Ozbulut.   

Abstract

Paradoxical therapy consists of suggesting that the patient intentionally engages in the unwanted behaviour such as performing compulsive ritual or wanting a conversion attack. In this study, the subjects were selected by the emergency unit psychiatrist from patients who were admitted to the emergency unit with pseudoseizure. The diagnoses was based on DSM-IV criteria. Paradoxical intention was applied to half of the 30 patients with conversion disorders; the other half were treated with diazepam in order to examine the efficiency of the paradoxical intention versus diazepam. In both groups the differences of the anxiety scores at the beginning of the study were found to be insignificant (z=1.08, p=0.28). Of the 15 patients who completed paradoxical intention treatment, 14 (93.3%) responded favorably to paradoxical intention. On the other hand of 15 patients who completed diazepam therapy, 9 (60%) responded well to therapy and 6 patients carried on their conversion symptoms at the end of 6 weeks. Paradoxical intention-treated patients appeared to have greater improvements in anxiety scores (z=2.43, p<0.015) and conversion symptoms (t=2.27, p=0.034) than the diazepam-treated patients. The results of the present study are encouraging in that paradoxical intention can be effective in the treatment of conversion disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923337      PMCID: PMC3055095          DOI: 10.3346/jkms.2003.18.4.581

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  12 in total

Review 1.  Conversion disorder: advances in our understanding.

Authors:  Anthony Feinstein
Journal:  CMAJ       Date:  2011-04-18       Impact factor: 8.262

Review 2.  Conversion Disorder, Functional Neurological Symptom Disorder, and Chronic Pain: Comorbidity, Assessment, and Treatment.

Authors:  Patricia Tsui; Andrew Deptula; Derek Y Yuan
Journal:  Curr Pain Headache Rep       Date:  2017-06

Review 3.  Treatment of psychogenic nonepileptic seizures: updated review and findings from a mindfulness-based intervention case series.

Authors:  Gaston Baslet; Barbara Dworetzky; David L Perez; Megan Oser
Journal:  Clin EEG Neurosci       Date:  2014-12-02       Impact factor: 1.843

4.  A Therapeutic Approach to Psychogenic Nonepileptic Seizures.

Authors:  M Ayman Haykal; Brien Smith
Journal:  Curr Treat Options Neurol       Date:  2015-09       Impact factor: 3.598

Review 5.  Dissociative seizures: a challenge for neurologists and psychotherapists.

Authors:  Kurt Fritzsche; Kathrin Baumann; Katrin Götz-Trabert; Andreas Schulze-Bonhage
Journal:  Dtsch Arztebl Int       Date:  2013-04-12       Impact factor: 5.594

Review 6.  Recent developments in our understanding of the semiology and treatment of psychogenic nonepileptic seizures.

Authors:  Laura H Goldstein; John D C Mellers
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

Review 7.  Management of Functional Vision Disorders.

Authors:  Ragini Phansalkar; A Juliana Lockman; Surbhi Bansal; Heather E Moss
Journal:  Curr Neurol Neurosci Rep       Date:  2022-03-23       Impact factor: 6.030

8.  Psychosocial interventions for conversion and dissociative disorders in adults.

Authors:  Christina A Ganslev; Ole Jakob Storebø; Henriette E Callesen; Rachel Ruddy; Ulf Søgaard
Journal:  Cochrane Database Syst Rev       Date:  2020-07-17

Review 9.  Psychogenic Nonepileptic Seizures and Psychosocial Management: A Narrative Review.

Authors:  Nisha Phakey; Karishma Godara; Divyani Garg; Suvasini Sharma
Journal:  Ann Indian Acad Neurol       Date:  2021-03-31       Impact factor: 1.383

10.  Outcome measurement in functional neurological disorder: a systematic review and recommendations.

Authors:  Susannah Pick; David G Anderson; Ali A Asadi-Pooya; Selma Aybek; Gaston Baslet; Bastiaan R Bloem; Abigail Bradley-Westguard; Richard J Brown; Alan J Carson; Trudie Chalder; Maria Damianova; Anthony S David; Mark J Edwards; Steven A Epstein; Alberto J Espay; Béatrice Garcin; Laura H Goldstein; Mark Hallett; Joseph Jankovic; Eileen M Joyce; Richard A Kanaan; Roxanne C Keynejad; Kasia Kozlowska; Kathrin LaFaver; W Curt LaFrance; Anthony E Lang; Alex Lehn; Sarah Lidstone; Carine W Maurer; Bridget Mildon; Francesca Morgante; Lorna Myers; Clare Nicholson; Glenn Nielsen; David L Perez; Stoyan Popkirov; Markus Reuber; Karen S Rommelfanger; Petra Schwingenshuh; Tereza Serranova; Paul Shotbolt; Glenn T Stebbins; Jon Stone; Marina Aj Tijssen; Michele Tinazzi; Timothy R Nicholson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-02-28       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.